CITIUS ONCOLOGY, INC. (CTOR) — Shareholders' Equity
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2025 | $44.87M | -2.8% |
| 2024 | $46.14M | +2421.5% |
| 2023 | -$1.99M | -675.3% |
| 2022 | $345.5K | +3516.5% |
| 2021 | -$10.1K | — |
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2025 | $44.87M | -2.8% |
| 2024 | $46.14M | +2421.5% |
| 2023 | -$1.99M | -675.3% |
| 2022 | $345.5K | +3516.5% |
| 2021 | -$10.1K | — |